Adipose mesenchymal stem cell-derived exosomes rescue mitochondrial function through SIRT1 to improve diabetic wound healing

Abstract

Background: Diabetic wounds represent the most common type of chronic wounds. Persistent inflammation and elevated oxidative stress are hallmark features of chronic wounds, where macrophage phenotypic polarization playing a critical role in the healing process. Adipose-derived mesenchymal stem cell exosomes (ADSC-exos) have shown promising therapeutic effects in the treatment of diabetic wounds by modulating macrophage function. This study aims to elucidate the specific downstream regulatory mechanisms through both in vitro and in vivo investigations. Methods: A streptozotocin-induced diabetic mouse model and high glucose-stimulated RAW 264.7 macrophages were utilized to mimic diabetic microenvironments. Wound tissues were collected from patients with diabetic foot ulcer. A skin incision model was established in mice and ADSC-exos were given subcutaneously. Streptozotocin-induced diabetic myeloid-specific sirt1^−/− mice SIRT1 siRNA-transfected macrophages were employed to investigate the role of SIRT1 in vivo and in vitro. Wound healing rates were quantified. Mitochondrial function, lysosomal activity, autophagy flux, and inflammation status were systematically assessed. Results: In diabetic mice and high glucose-treated macrophages, lysosomal dysfunction preceded mitochondrial and autophagy flux impairments. SIRT1 expression was significantly reduced in both diabetic wound tissues and macrophages, accompanied by M1 macrophage polarization. SIRT1 interference experiments revealed that the impact of ADSC-exos on mitochondrial function, autophagy flux, and inflammatory response were partially dependent on SIRT1. Notably, the therapeutic effects of ADSC-exos on mitochondrial and autophagic pathways were markedly attenuated upon SIRT1 suppression. Conclusions: These findings demonstrate that ADSC-exos promotes diabetic wound healing by restoring mitochondrial function and autophagy via SIRT1 activation. These findings highlight the therapeutic potential of ADSC-exos and provide a mechanistic foundation for future exosome engineering strategies.

Keywords

Diabetic wounds / Adipose mesenchymal stem cell derived-exosomes / SIRT1 / Mitochondrial / Autophagy flux / Lysosome

References

[1] Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022; 183: 109119. https://doi.org/10.1016/j.diabres.2021.109119.

[2] Armstrong DG, Tan TW, Boulton AJM, Bus SA. Diabetic foot ulcers: a review. JAMA 2023; 330: 62-75. https://doi.org/10.1001/jama.2023.10578.

[3] Deldar R, Merle C, Attinger CE, Evans KK. Soft tissue coverage of lower extremity defects: pearls and pitfalls in the chronic wound population. Plast Aesthet Res 2022; 9: 13. https://doi.org/10.20517/2347-9264.2021.100.

[4] Das A, Sinha M, Datta S, Abas M, Chaffee S, Sen CK, et al. Monocyte and macrophage plasticity in tissue repair and regeneration. Am J Pathol 2015; 185: 2596-606. https://doi.org/10.1016/j.ajpath.2015.06.001.

[5] Roy R, Zayas J, Mohamed MF, Aboonabi A, Delgado K, Wallace J, et al. IL-10 dysregulation underlies chemokine insufficiency, delayed macrophage response, and impaired healing in diabetic wounds. J Invest Dermatol 2022; 142: 692-704.e14. https://doi.org/10.1016/j.jid.2021.08.428.

[6] Louiselle AE, Niemiec SM, Zgheib C, Liechty KW. Macrophage polarization and diabetic wound healing. Transl Res 2021; 236: 109-16. https://doi.org/10.1016/j.trsl.2021.05.006.

[7] Aitcheson SM, Frentiu FD, Hurn SE, Edwards K, Murray RZ. Skin wound healing: normal macrophage function and macrophage dysfunction in diabetic wounds. Molecules 2021; 26: 4917. https://doi.org/10.3390/molecules26164917.

[8] Wu X, He W, Mu X, Liu Y, Deng J, Liu Y, et al. Macrophage polarization in diabetic wound healing. Burns Trauma 2022; 10: tkac051. https://doi.org/10.1093/burnst/tkac051.

[9] Sindrilaru A, Peters T, Wieschalka S, Baican C, Baican A, Peter H, et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest 2011; 121: 985-97. https://doi.org/10.1172/JCI44490.

[10] Yuan Y, Chen Y, Peng T, Li L, Zhu W, Liu F, et al. Mitochondrial ROS-induced lysosomal dysfunction impairs autophagic flux and contributes to M1 macrophage polarization in a diabetic condition. Clin Sci (Lond) 2019; 133: 1759-77. https://doi.org/10.1042/CS20190672.

[11] Wang Y, Li N, Zhang X, Horng T. Mitochondrial metabolism regulates macrophage biology. J Biol Chem 2021; 297: 100904. https://doi.org/10.1016/j.jbc.2021.100904.

[12] Willenborg S, Sanin DE, Jais A, Ding X, Ulas T, Nuchel J, et al. Mitochondrial metabolism coordinates stage-specific repair processes in macrophages during wound healing. Cell Metab 2021; 33: 2398-2414.e9. https://doi.org/10.1016/j.cmet.2021.10.004.

[13] Chen S, Saeed A, Liu Q, Jiang Q, Xu H, Xiao GG, et al. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther 2023; 8: 207. https://doi.org/10.1038/s41392-023-01452-1.

[14] Cortes M, Brischetto A, Martinez-Campanario MC, Ninfali C, Dominguez V, Fernandez S, et al. Inflammatory macrophages reprogram to immunosuppression by reducing mitochondrial translation. Nat Commun 2023; 14: 7471. https://doi.org/10.1038/s41467-023-42277-4.

[15] Yang Y, Liu Y, Wang Y, Chao Y, Zhang J, Jia Y, et al. Regulation of SIRT1 and its roles in inflammation. Front Immunol 2022; 13: 831168. https://doi.org/10.3389/fimmu.2022.831168.

[16] Lu C, Zhao H, Liu Y, Yang Z, Yao H, Liu T, et al. Novel role of the SIRT1 in endocrine and metabolic diseases. Int J Biol Sci 2023; 19: 484-501. https://doi.org/10.7150/ijbs.78654.

[17] Parsamanesh N, Asghari A, Sardari S, Tasbandi A, Jamialahmadi T, Xu S, et al. Resveratrol and endothelial function: a literature review. Pharmacol Res 2021; 170: 105725. https://doi.org/10.1016/j.phrs.2021.105725.

[18] Kane AE, Sinclair DA. Sirtuins and NAD(+) in the development and treatment of metabolic and cardiovascular diseases. Circ Res 2018; 123: 868-85. https://doi.org/10.1161/CIRCRESAHA.118.312498.

[19] Zhang M, Qiang Y. Catalpol ameliorates inflammation and oxidative stress via regulating Sirt1 and activating Nrf2/HO-1 signaling against acute kidney injury. Environ Toxicol 2023; 38: 2182-91. https://doi.org/10.1002/tox.23855.

[20] Kim KE, Jeong EA, Lee JY, Yi CO, Park KA, Jin Z, et al. Myeloid sirtuin1 deficiency aggravates hippocampal inflammation in mice fed high-fat diets. Biochem Biophys Res Commun 2018; 499: 1025-31. https://doi.org/10.1016/j.bbrc.2018.04.044.

[21] Ka SO, Song MY, Bae EJ, Park BH. Myeloid SIRT1 regulates macrophage infiltration and insulin sensitivity in mice fed a high-fat diet. J Endocrinol 2015; 224: 109-18. https://doi.org/10.1530/JOE-14-0527.

[22] He T, Bai X, Li Y, Zhang D, Xu Z, Yang X, et al. Insufficient SIRT1 in macrophages promotes oxidative stress and inflammation during scarring. J Mol Med (Berl) 2023; 101: 1397-407. https://doi.org/10.1007/s00109-023-02364-x.

[23] Costantino S, Mengozzi A, Velagapudi S, Mohammed SA, Gorica E, Akhmedov A, et al. Treatment with recombinant Sirt1 rewires the cardiac lipidome and rescues diabetes-related metabolic cardiomyopathy. Cardiovasc Diabetol 2023; 22: 312. https://doi.org/10.1186/s12933-023-02057-2.

[24] Yang K, Velagapudi S, Akhmedov A, Kraler S, Lapikova-Bryhinska T, Schmiady MO, et al. Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress. Cardiovasc Res 2023; 119: 2190-201. https://doi.org/10.1093/cvr/cvad102.

[25] Fu X, Liu G, Halim A, Ju Y, Luo Q, Song AG. Mesenchymal stem cell migration and tissue repair. Cells 2019; 8: 8. https://doi.org/10.3390/cells8080784.

[26] Si Z, Wang X, Sun C, Kang Y, Xu J, Wang X, et al. Adipose-derived stem cells: sources, potency, and implications for regenerative therapies. Biomed Pharmacother 2019; 114: 108765. https://doi.org/10.1016/j.biopha.2019.108765.

[27] Shi Y, Wang Y, Li Q, Liu K, Hou J, Shao C, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol 2018; 14: 493-507. https://doi.org/10.1038/s41581-018-0023-5.

[28] Yu S, Cheng Y, Zhang L, Yin Y, Xue J, Li B, et al. Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats. Stem Cell Res Ther 2019; 10: 333. https://doi.org/10.1186/s13287-019-1474-8.

[29] Zhu M, Cao L, Melino S, Candi E, Wang Y, Shao C, et al. Orchestration of mesenchymal stem/stromal cells and inflammation during wound healing. Stem Cells Transl Med 2023; 12: 576-87. https://doi.org/10.1093/stcltm/szad043.

[30] Bian D, Wu Y, Song G, Azizi R, Zamani A. The application of mesenchymal stromal cells (MSCs) and their derivative exosome in skin wound healing: a comprehensive review. Stem Cell Res Ther 2022; 13: 24. https://doi.org/10.1186/s13287-021-02697-9.

[31] Ha DH, Kim HK, Lee J, Kwon HH, Park GH, Yang SH, et al. Mesenchymal stem/stromal cell-derived exosomes for immunomodulatory therapeutics and skin regeneration. Cells 2020; 9: 9. https://doi.org/10.3390/cells9051157.

[32] Li B, Qian L, Pi L, Meng X. A therapeutic role of exosomal lncRNA H19 from adipose mesenchymal stem cells in cutaneous wound healing by triggering macrophage M2 polarization. Cytokine 2023; 165: 156175. https://doi.org/10.1016/j.cyto.2023.156175.

[33] Li R, Li D, Wang H, Chen K, Wang S, Xu J, et al. Exosomes from adipose-derived stem cells regulate M1/M2 macrophage phenotypic polarization to promote bone healing via miR-451a/MIF. Stem Cell Res Ther 2022; 13: 149. https://doi.org/10.1186/s13287-022-02823-1.

[34] Ni HM, Williams JA, Ding WX. Mitochondrial dynamics and mitochondrial quality control. Redox Biol 2015; 4: 6-13. https://doi.org/10.1016/j.redox.2014.11.006.

[35] Ma X, Chen A, Melo L, Clemente-Sanchez A, Chao X, Ahmadi AR, et al. Loss of hepatic DRP1 exacerbates alcoholic hepatitis by inducing megamitochondria and mitochondrial maladaptation. Hepatology 2023; 77: 159-75. https://doi.org/10.1002/hep.32604.

[36] Elbatreek MH, Pachado MP, Cuadrado A, Jandeleit-Dahm K, Schmidt H. Reactive oxygen comes of age: mechanism-based therapy of diabetic end-organ damage. Trends Endocrinol Metab 2019; 30: 312-27. https://doi.org/10.1016/j.tem.2019.02.006.

[37] Koulis C, Watson AMD, Gray SP, Jandeleit-Dahm KA. Linking RAGE and Nox in diabetic micro-and macrovascular complications. Diabetes Metab 2015; 41: 272-81. https://doi.org/10.1016/j.diabet.2015.01.006.

[38] Dong T, Chen X, Xu H, Song Y, Wang H, Gao Y, et al. Mitochondrial metabolism mediated macrophage polarization in chronic lung diseases. Pharmacol Ther 2022; 239: 108208. https://doi.org/10.1016/j.pharmthera.2022.108208.

[39] Weissman D, Maack C. Mitochondrial function in macrophages controls cardiac repair after myocardial infarction. J Clin Invest 2023; 133. https://doi.org/10.1172/JCI167079.

[40] Wada J, Nakatsuka A. Mitochondrial dynamics and mitochondrial dysfunction in diabetes. Acta Med Okayama 2016; 70: 151-8.

[41] Steinberg GR, Kemp BE. AMPK in health and disease. Physiol Rev 2009; 89: 1025-78. https://doi.org/10.1152/physrev.00011.2008.

[42] Jager S, Handschin C, St-Pierre J, Spiegelman BM. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci USA 2007; 104: 12017-22. https://doi.org/10.1073/pnas.0705070104.

[43] Navarro-Gonzalez JF, Mora-Fernandez C, Muros de Fuentes M, Chahin J, Mendez ML, Gallego E, et al. Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: the PREDIAN trial. J Am Soc Nephrol 2015; 26: 220-9. https://doi.org/10.1681/ASN.2014010012.

[44] An Y, Zhang H, Wang C, Jiao F, Xu H, Wang X, et al. Activation of ROS/MAPKs/NF-kappaB/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis. FASEB J 2019; 33: 12515-27. https://doi.org/10.1096/fj.201802805RR.

[45] Fernandez-Mosquera L, Yambire KF, Couto R, Pereyra L, Pabis K, Ponsford AH, et al. Mitochondrial respiratory chain deficiency inhibits lysosomal hydrolysis. Autophagy 2019; 15: 1572-91. https://doi.org/10.1080/15548627.2019.1586256.

[46] Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Erdin S, et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J 2012; 31: 1095-108. https://doi.org/10.1038/emboj.2012.32.

[47] Tan A, Prasad R, Lee C, Jho EH. Past, present, and future perspectives of transcription factor EB (TFEB): mechanisms of regulation and association with disease. Cell Death Differ 2022; 29: 1433-49. https://doi.org/10.1038/s41418-022-01028-6.

[48] Rabinovich-Nikitin I, Rasouli M, Reitz CJ, Posen I, Margulets V, Dhingra R, et al. Mitochondrial autophagy and cell survival is regulated by the circadian clock gene in cardiac myocytes during ischemic stress. Autophagy 2021; 17: 3794-812. https://doi.org/10.1080/15548627.2021.1938913.

[49] Jiang Y, Zhao Y, Zhu X, Liu Y, Wu B, Guo Y, et al. Effects of autophagy on macrophage adhesion and migration in diabetic nephropathy. Ren Fail 2019; 41: 682-90. https://doi.org/10.1080/0886022X.2019.1632209.

[50] Wang X, Chen S, Lu R, Sun Y, Song T, Nie Z, et al. Adipose-derived stem cell-secreted exosomes enhance angiogenesis by promoting macrophage M2 polarization in type 2 diabetic mice with limb ischemia via the JAK/STAT6 pathway. Heliyon 2022; 8: e11495. https://doi.org/10.1016/j.heliyon.2022.e11495.

[51] Abdellatif M, Sedej S, Kroemer G. NAD(+) metabolism in cardiac health, aging, and disease. Circulation 2021; 144: 1795-817. https://doi.org/10.1161/CIRCULATIONAHA.121.056589.

[52] Verdin E.NAD(+) in aging, metabolism, and neurodegeneration. Science 2015; 350: 1208-13. https://doi.org/10.1126/science.aac4854.

[53] Cui Z, Zhao X, Amevor FK, Du X, Wang Y, Li D, et al. Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism. Front Immunol 2022; 13: 943321. https://doi.org/10.3389/fimmu.2022.943321.

[54] Li X, Wu G, Han F, Wang K, Bai X, Jia Y, et al. SIRT1 activation promotes angiogenesis in diabetic wounds by protecting endothelial cells against oxidative stress. Arch Biochem Biophys 2019; 661: 117-24. https://doi.org/10.1016/j.abb.2018.11.016.